טוען...
‘Future-proofing’ blood processing for measurement of circulating microRNAs in samples from biobanks and prospective clinical trials
BACKGROUND: Quantifying circulating nucleic-acids is an important new approach to cancer diagnosis/monitoring. METHODS: We compared the suitability of serum versus plasma for measuring microRNAs using RT-qPCR and assessed how pre-analytical variables that can affect circulating-tumor-DNA (ctDNA) qua...
שמור ב:
| הוצא לאור ב: | Cancer Epidemiol Biomarkers Prev |
|---|---|
| Main Authors: | , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5812437/ https://ncbi.nlm.nih.gov/pubmed/29254935 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1055-9965.EPI-17-0657 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|